Evidence map›Paper›PMID 14973382›Full record

ReviewJournal of mammary gland biology and neoplasia2000

Culture models of human mammary epithelial cell transformation.

M R Stampfer, P Yaswen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Significance of telomere capture in myelodysplastic syndromes.Medical oncology (Northwood, London, England) · 2014
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. [Relevance of cell culture models in cutaneous tumour biology. Part I: tumour cell lines].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2008
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M R StampferLawrence Berkeley National Laboratory, University of California, Life Sciences Division, Berkeley 94720, USA. mrstampfer@lbl.gov
P Yaswen
Lawrence Berkeley National Laboratory · US

Funding

HUMAN MAMMARY CELLSR01CA024844 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI STAMPFER, MARTHA R · 1985 to 2002
$1.6M
MAMMARY CELLSR37CA024844 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI STAMPFER, MARTHA R · 1989 to 1997
–
NCI NIH HHS CA-24844
6 · The paper itself

Abstract

Human pre-malignant breast diseases, particularly ductal carcinoma in situ (DCIS) already display several of the aberrant phenotypes found in primary breast cancers, including chromosomal abnormalities, telomerase activity, inactivation of the p53 gene, and overexpression of some oncogenes. Efforts to model early breast carcinogenesis in human cell cultures have largely involved studies of in vitro transformation of normal finite lifespan human mammary epithelial cells (HMEC) to immortality and malignancy. We present a model of HMEC immortal transformation consistent with the known in vivo data. This model includes a recently described, presumably epigenetic process, termed conversion, which occurs in cells that have overcome stringent replicative senescence and are thus able to maintain proliferation with critically short telomeres. The conversion process involves reactivation of telomerase activity, and acquisition of good uniform growth in the absence and presence of TGFbeta. We propose that overcoming the proliferative constraints set by senescence, and undergoing conversion, represent key rate-limiting steps in human breast carcinogenesis, and occur during early stage breast cancer progression.

Indexed as

Breast NeoplasmsCells, CulturedCell Transformation, NeoplasticCellular SenescenceDisease Models, AnimalDNA-Binding ProteinsEpithelial CellsHumansMammary Glands, HumanModels, BiologicalPhenotypeTelomeraseTime FactorsTransforming Growth Factor betaTumor Suppressor Protein p53DNA-Binding ProteinsTelomeraseTransforming Growth Factor betaTumor Suppressor Protein p53

Identifiers

PMID14973382
OpenAlexW1498688899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.